Spyre Therapeutics, Inc. (SYRE)
80.11
-12.61
(-13.60%)
USD |
NASDAQ |
Oct 06, 16:00
80.11
0.00 (0.00%)
After-Hours: 20:00
Spyre Therapeutics Price : 80.11 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 92.08 | 92.08 | 79.36 | 80.11 | 4.252M |
| Oct 05, 2026 | 93.02 | 95.01 | 89.49 | 92.72 | 642857.0 |
| Oct 02, 2026 | 91.16 | 95.27 | 90.48 | 93.19 | 1.235M |
| Oct 01, 2026 | 89.13 | 94.06 | 87.25 | 89.93 | 1.663M |
| Sep 30, 2026 | 88.64 | 95.08 | 88.00 | 89.03 | 2.096M |
| Sep 29, 2026 | 85.09 | 86.64 | 83.26 | 84.72 | 1.053M |
| Sep 28, 2026 | 84.72 | 87.12 | 84.00 | 85.79 | 1.046M |
| Sep 25, 2026 | 88.10 | 88.10 | 85.63 | 85.69 | 560081.0 |
| Sep 24, 2026 | 87.46 | 87.46 | 82.93 | 87.09 | 1.730M |
| Sep 23, 2026 | 91.56 | 91.56 | 86.30 | 88.17 | 918770.0 |
| Sep 22, 2026 | 91.53 | 93.58 | 89.90 | 91.97 | 1.223M |
| Sep 21, 2026 | 91.07 | 94.06 | 89.65 | 92.03 | 1.449M |
| Sep 18, 2026 | 92.82 | 93.34 | 89.85 | 90.25 | 3.357M |
| Sep 17, 2026 | 92.86 | 95.19 | 91.14 | 92.68 | 1.439M |
| Sep 16, 2026 | 91.38 | 93.06 | 90.48 | 91.17 | 1.258M |
| Sep 15, 2026 | 90.82 | 91.07 | 88.47 | 90.95 | 858488.0 |
| Sep 14, 2026 | 90.21 | 91.40 | 89.43 | 90.80 | 1.101M |
| Sep 11, 2026 | 90.00 | 91.40 | 87.89 | 90.60 | 886055.0 |
| Sep 10, 2026 | 85.56 | 88.72 | 85.26 | 88.71 | 902459.0 |
| Sep 09, 2026 | 88.07 | 89.57 | 86.85 | 86.93 | 1.006M |
| Sep 08, 2026 | 85.00 | 92.10 | 85.00 | 90.79 | 1.250M |
| Sep 04, 2026 | 86.45 | 89.18 | 84.68 | 88.98 | 803857.0 |
| Sep 03, 2026 | 86.71 | 87.90 | 85.78 | 87.25 | 1.054M |
| Sep 02, 2026 | 88.05 | 90.18 | 84.00 | 87.05 | 1.362M |
| Sep 01, 2026 | 87.06 | 90.00 | 85.00 | 88.50 | 1.429M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 266.69 |
| Incyte Corp. | 112.73 |
| SELLAS Life Sciences Group, Inc. | 11.34 |
| Relay Therapeutics, Inc. | 18.74 |
| ACADIA Pharmaceuticals, Inc. | 19.74 |
Price Related Metrics
| Price to Book Value | 7.389 |
| Earnings Yield | -2.72% |
| Market Cap | 7.055B |